Prognostic significance of estrogen receptor status in de novo metastatic breast cancer

被引：0
|
作者：
Ren Chongxi [1 ]
Sun Jianna [1 ]
Kong Lingjun [1 ]
Luo Ruizhen [1 ]
Mu Kun [1 ]
Jiang Xiuzhen [1 ]
机构：
[1] Hebei Med Univ, Cangzhou Clin Coll Integrated Tradit Chinese & We, Cangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13049
引用
收藏
页数：1
相关论文
共 50 条
  • [31] PROGNOSTIC-SIGNIFICANCE OF ESTROGEN-RECEPTOR DETERMINATION IN PRIMARY BREAST-CANCER
    CIATTO, S
    PALLI, D
    IOSSA, A
    PACINI, P
    CATALIOTTI, L
    DISTANTE, V
    TEGLIA, C
    CARIDI, G
    MESSERI, G
    RADIOTHERAPY AND ONCOLOGY, 1988, 12 (03) : 187 - 192
  • [32] Surgical Treatment of de novo Metastatic Breast Cancer
    Rooney, Marguerite M.
    Miller, Krislyn N.
    Rosenberger, Laura H.
    Plichta, Jennifer K.
    CURRENT BREAST CANCER REPORTS, 2022, 14 (03) : 83 - 92
  • [33] Surgical Treatment of de novo Metastatic Breast Cancer
    Marguerite M. Rooney
    Krislyn N. Miller
    Laura H. Rosenberger
    Jennifer K. Plichta
    Current Breast Cancer Reports, 2022, 14 : 83 - 92
  • [34] Genomic Characterization of De Novo Metastatic Breast Cancer
    Mullangi, Samyukta
    Vasan, Neil
    CLINICAL BREAST CANCER, 2022, 22 (02) : 98 - 102
  • [35] Re: Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer - Response
    Swain, SM
    Wilson, JW
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (13) : 1041 - 1041
  • [36] Genomic Characterization of de novo Metastatic Breast Cancer
    Garrido-Castro, Ana C.
    Spurr, Liam F.
    Hughes, Melissa E.
    Li, Yvonne Y.
    Cherniack, Andrew D.
    Kumari, Priti
    Lloyd, Maxwell R.
    Bychkovsky, Brittany
    Barroso-Sousa, Romualdo
    Di Lascio, Simona
    Jain, Esha
    Files, Janet
    Mohammed-Abreu, Ayesha
    Krevalin, Max
    MacKichan, Colin
    Barry, William T.
    Guo, Hao
    Xia, Daniel
    Cerami, Ethan
    Rollins, Barrett J.
    MacConaill, Laura E.
    Lindeman, Neal, I
    Krop, Ian E.
    Johnson, Bruce E.
    Wagle, Nikhil
    Winer, Eric P.
    Dillon, Deborah A.
    Lin, Nancy U.
    CLINICAL CANCER RESEARCH, 2021, 27 (04) : 1105 - 1118
  • [37] METASTATIC BREAST CANCER: PROGNOSTIC FACTORS OF SURVIVAL AND THE DIFFERENCE BETWEEN DE NOVO AND RECURRENT DISEASE
    Rommel, Kim
    Ettl, Johannes
    Kiechle, Marion
    Bronger, Holger
    ANTICANCER RESEARCH, 2023, 43 (07) : 3375 - 3375
  • [38] The metastasis patterns and their prognostic features in patients with de novo metastatic breast cancer of different ages
    Sun, Shujuan
    Man, Xiaochu
    Zhou, Dongdong
    Zheng, Fangchao
    Zhao, Jiuda
    Chen, Xuesong
    Liu, Tong
    Huang, Jie
    Tan, Qiaorui
    Li, Na
    Li, Huihui
    CANCER MEDICINE, 2023, 12 (18): : 18850 - 18860
  • [39] INFLUENCE OF ESTROGEN-RECEPTOR (ER) STATUS ON SURVIVAL IN METASTATIC BREAST-CANCER
    MORTIMER, J
    REIMER, RR
    BUKOWSKI, RM
    GROPPE, C
    GREENSTREET, RL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 144 - 144
  • [40] RESPONSE TO CHEMOTHERAPY IN METASTATIC BREAST-CANCER IN RELATION TO ESTROGEN-RECEPTOR STATUS
    ROSNER, D
    NEMOTO, T
    LANE, WW
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 197 - 197
12345